Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/pb123/public_html/wp-includes/functions.php on line 6114
PartitionBio
PartitionBio

PartitionBio

Exploiting a proprietary technology platform to develop biomolecular tools for therapeutic and synthetic biology applications

About us

The past decade has seen an explosion of scientific insight into the significance of membraneless organelles (MLOs) for cellular physiology and organisation, both in health and disease. Dysfunctions associated with MLOs include neurodegenerative diseases, cancers and viral infections. This silent revolution in cell biology has been accompanied and accelerated by an emerging understanding of the biophysical mechanism underlying the formation of MLOs, in particular the role of liquid-liquid phase separation (LLPS) of biomolecules.

Where we come from

Niall Armes PhD, is the scientific founder of PartitionBio. In previous ventures, TwistDx and Biocrucible he has pioneered the exploitation of LLPS-dependent biomolecular condensates (BMC) for the acceleration of enzyme kinetics in in vitro reaction systems, particularly for the building of DNA amplification machines using disordered protein engineering solutions. Dr Armes and co-workers will apply their insight to the therapeutic opportunities emerging in the disruptive field of biopolymer phase separation in live cell systems.

Who we are

The team of scientists at PartitionBio combines expertise in a range of biomedically relevant areas, including protein-engineering and condensate biology, as well as medicinal chemistry and high-throughput microscopy screening. The company’s mission is to deploy this know-how and the emerging understanding of LLPS to develop therapeutic solutions for condensate-associated diseases and innovative tools for synthetic biology applications.

Senior Management Team

Dr Niall Armes

Founder & Director

Dr Olaf Piepenburg

Managing Director

Helen Kent-Armes

Director & COO

Dr David Brooks

Director

Namal Nawana

Director

Team

Dr Ian Cook

Lead Scientist

Dr Clare Simpson

Lead Scientist

Dr Oliver Nentwich

Principal Scientist

Dr Zehra Nizami

Principal Scientist

Dr Barbara Tavares

Lead Scientist

Mona Katariya

Lead Scientist

Caroline Orros

Office Manager

Dr Puneet Srivastava

Lead Scientist

Sarah Gibbs

Senior Research Assistant

News

Contact

Suite 9 & 14, Science Village
Chesterford Research Park
Little Chesterford
Saffron Walden, CB10 1XL